Literature DB >> 35098317

Effect of Beta-blockers on Extracranial Arteriovenous Malformations.

Sarah Chastanet1, Annabel Maruani, Boris Laure, Denis Herbreteau, Aline Joly.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35098317      PMCID： PMC9558755          DOI： 10.2340/actadv.v102.1412

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  13 in total

1.  Beta blockade induces apoptosis in cultured capillary endothelial cells.

Authors:  Sally K Sommers Smith; Dennis M Smith
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-05       Impact factor: 2.416

2.  Extracranial arteriovenous malformations: natural progression and recurrence after treatment.

Authors:  Allen S Liu; John B Mulliken; David Zurakowski; Steven J Fishman; Arin K Greene
Journal:  Plast Reconstr Surg       Date:  2010-04       Impact factor: 4.730

3.  Oral propranolol as palliative treatment for a recurrent arteriovenous malformation.

Authors:  Pedro Rodríguez-Jiménez; Marta Uceda; Jose Luis Ramirez-Bellver; Ricardo Ruiz-Rodríguez; Ignacio Sánchez-Carpintero
Journal:  Dermatol Ther       Date:  2019-09-04       Impact factor: 2.851

4.  Efficacy and safety of embolization in arteriovenous malformations of the extremities and head and neck: a retrospective study of 32 cases.

Authors:  Élodie Le Fourn; Denis Herbreteau; Chrysanthi Papagiannaki; Gérard Lorette; Dominique Sirinelli; Dominique Goga; Annabel Maruani
Journal:  Eur J Dermatol       Date:  2015 Jan-Feb       Impact factor: 3.328

5.  Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia.

Authors:  Virginia Albiñana; Lucía Recio-Poveda; Roberto Zarrabeitia; Carmelo Bernabéu; Luisa María Botella
Journal:  Thromb Haemost       Date:  2012-05-03       Impact factor: 5.249

6.  A randomized, controlled trial of oral propranolol in infantile hemangioma.

Authors:  Christine Léauté-Labrèze; Peter Hoeger; Juliette Mazereeuw-Hautier; Laurent Guibaud; Eulalia Baselga; Gintas Posiunas; Roderic J Phillips; Hector Caceres; Juan Carlos Lopez Gutierrez; Rosalia Ballona; Sheila Fallon Friedlander; Julie Powell; Danuta Perek; Brandie Metz; Sebastien Barbarot; Annabel Maruani; Zsuzsanna Zsofia Szalai; Alfons Krol; Olivia Boccara; Regina Foelster-Holst; Maria Isabel Febrer Bosch; John Su; Hana Buckova; Antonio Torrelo; Frederic Cambazard; Rainer Grantzow; Orli Wargon; Dariusz Wyrzykowski; Jochen Roessler; Jose Bernabeu-Wittel; Adriana M Valencia; Przemyslaw Przewratil; Sharon Glick; Elena Pope; Nicholas Birchall; Latanya Benjamin; Anthony J Mancini; Pierre Vabres; Pierre Souteyrand; Ilona J Frieden; Charles I Berul; Cyrus R Mehta; Sorilla Prey; Franck Boralevi; Caroline C Morgan; Stephane Heritier; Alain Delarue; Jean-Jacques Voisard
Journal:  N Engl J Med       Date:  2015-02-19       Impact factor: 91.245

7.  Efficacy and Tolerance of Sirolimus (Rapamycin) for Extracranial Arteriovenous Malformations in Children and Adults.

Authors:  Romain Gabeff; Olivia Boccara; Véronique Soupre; Gérard Lorette; Christine Bodemer; Denis Herbreteau; Elsa Tavernier; Annabel Maruani
Journal:  Acta Derm Venereol       Date:  2019-11-01       Impact factor: 4.437

8.  Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.

Authors:  Elisabetta Buscarini; Luisa Maria Botella; Urban Geisthoff; Anette D Kjeldsen; Hans Jurgen Mager; Fabio Pagella; Patrizia Suppressa; Roberto Zarrabeitia; Sophie Dupuis-Girod; Claire L Shovlin
Journal:  Orphanet J Rare Dis       Date:  2019-02-04       Impact factor: 4.123

9.  Propranolol as a potentially novel treatment of arteriovenous malformations.

Authors:  Jianyun Lu; Radean Anvari; Jinwei Wang; Jian Huang; Shiyao Pei; Yaping Xiang; Jinhua Huang; Zhaoqi Yin; Jing Chen; J Stuart Nelson; Wenbin Tan
Journal:  JAAD Case Rep       Date:  2018-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.